UUID: 604A3978- 4CSB- 4E9ﬂ- 3859- CCM7BB£9eCFSac
TCGA- VL- ABSB- BlA- PR

||| ||||IIIIIIIII||||||||||||||||II|I|I|I|IIII|||||||I||IIe||||||||I(Ed
||| ||||II||||II||I|I||| IIIIIIIIIIIIIIIII||lI||l||I|||||III||||||
Ill IIIIII||||I|||||||IIIll|lII|I||||||||||||||III|II||||||||||II

PROSTATE AND OBTURATOR LYMPH NODES; RADICAL PROSTAT§CTOMYz
TUMOR PROCUREMENT:
HISTOLOGIC TYPE

ACINAR ADENOCARCINOMA
~ HISTOLOGIC GRADE (PRIMARY PATTERN+SECONDARY PATI'ERN = GLEASON SCORE):

4 + 5 = 9 . ,

TERTIARY PATTERN NOT PRESENT 5W “”4 P“ PM
PERCENTAGE OF DIFFERENT GLEASON PATTERNS , w. .

1:_% 430qu g f

2:__% . .

3:___% 11(0) '0 , :5

4: 90%

TUNEIIDAOEOCATION adj/Mtgg/zw Izzy/MC) N53 91%3/13
APEX A I “a
BASE 5J1. ﬂJnﬁ MD; (M. ‘7

ANTERIOR
RIGHT ' \, ‘ - L.
LEFT (>4 V, 4172;77/ I
POSTERIOR ,
RIGHT
LEFT
EXTRA-PROSTATIC EXTENSION
PRESENT
NON-FOCAL
SITE OF EXTRA-PROSTATIC EXTENSION
RIGHT BASE
ANTERIOR
LEFT
POSTERIOR
LEFT
SEMINAL VESICAL INVASION
ABSENT
SURGICAL MARGINS
INVOLVED BY INVASIVE CARCINOMA
APEX (LEFT POSTERIOR)
NATURE OF POSITIVE MARGINS
IN AREAS OF EXTRA-PROSTATIC EXTENSION
EXTENT OF POSITIVE MARGINS
MULTIFOCAL
MILLIMETRIC EXTENT OF POSITIVE MARGINSZ NOT REPORTED
GLEASON GRADE OF CARCINOMA PRESENT AT THE POSITIVE MARGINS
NOT REPORTED
LYMPHOVASCULAR INVASION
NOT REPORTED
PERINEURAL INVASION
PRESENT
TUMOR VOLUME
PROPORTION OF PROSTATE INVOLVED BY CARCINOMA: 50%
TREATMENT EFFECT ON CARCINOMA
NOT APPLICABLE
LYMPH NODES
RIGHT OBTURATOR
NUMBER OF NODES INDENTIFIEDZ 6_

 

NUMBER OF NODES INVOLVED BY METASTASIS: 0_
LEFT OBTURATOR _
NUMBER OF NODES IDENTIFIED: 4_
NUMBER OF NODES INVOLVED BY METASTASIS: _0_
ADDITIONAL PATHOLOGIC FINDINGS
HIGH-GRADE PROSTATIC INTRA-EPITHELIAL NEOPLASIA
PATHOLOGICAL STAGING
pT3a
pNO
pMX

 

 

 

TCGA Pathologic Diagnosis Discrepancy Form

1‘14!“

 

 

 

 

 

 

 

Tissue Suulbt‘,‘ one [155):

motions; The TCGA Pathologic Diagnosis Discrepancy Form should be completed when the‘pathologic diagnosis
documented on the initial pathology reportfor a case submitted for TCGA is inconsistent with the diagnosis provided on the
Case Quality Control Form completed for the submitted case.

 

 

TSS Identiﬁer: ‘

Completed By (Interviewer Name on OpenCllnica): _ , kw ,

__ TSS Unique Patient Identiﬁer:

 

_.____Completed Date: _1

 

 

Diagnosis Information

 

 

 

 

ii Data Element Entry Alternatives Working instructions
;' ‘ l '- I w 1 {I G: 1) Provide the diagnosis] histologic sulItype[s] documented on

Pathologic Diagnosis ")ij ﬁat-’A’UC’ N6 M4 the initial pathology report for this case. II“ the histology for

1 Provided on Initial i_ ————-—— this case Is mixed, provide all listed subtypes.
- ' ( f‘ :r »
Pathology Report 6CCWJ0AJ ’( 5 9
. . | . - ,I , Provide the histologic features selected on the TCGA Case
n. I , LI
325:0]ng {gnu-:5 3f 4am #6”: NC" at,” ”4 Quality Control Form completed for this case.
m E FOVI e

2 {OE‘I‘I‘EGR afrellected _ "J “N (1/ 4‘ _ ,.

onthe CQCF. 510’“ ’* ‘ J

 

 

[Discrepancy between Pathology Report and Case Quality Control Form

 

4* 3

Provide the reason for
the discrepancy
between the pathology
report and the TCGA
Case Quality Control
Form.

ﬂu:- ufet‘g‘) Sin/ﬂu; (swan—3)

MM Romeo 4,1

(Sh’ﬂ’ulté: @5115)

Provide a reason describing why the diagnosis on the initial
pathology report for this case is not consistent with the
diagnosis sclcd‘ed on the TCGA Case Quality Control Form,

 

 

Name OI'I‘SS Reviewing
Pathologist or

 

 

Biorcpositury Director

Provide the name Of the pathologist who reviewed this case
[or TCGA.

 

 

 

I acknowledge that the above Information provided by my Institution is true and correct and has been quality controlled.

 

TSS Reviewing PathOIogIst or blorepumuu y Director

Date

I acknowledge that the above Information provided by my Institution Is true and correct and has been quality controlled. The/Ittondiay Pathologist or the
Department Chairman has been Informed or Is aware of the above dlscrepancy In diagnoses.

 

Prin’eipal Iﬁvestigator Signature

Date

 

